Introduction
============

In septic shock, arginine--vasopressin (AVP) infusion efficiently maintains the mean arterial pressure (MAP), but may compromise hepatosplanchnic perfusion due to excessive vasoconstriction and, thus, depress whole-body and regional substrate metabolism. In this context, the underlying hemodynamic status is crucial \[[@B1]\]. We therefore compared the effects of noradrenaline (NA) and AVP on hepatosplanchnic blood flow, whole body glucose oxidation and hepatic gluconeogenesis during resuscitated, hyperdynamic septic shock.

Methods
=======

After intraperitoneal faeces inoculation \[[@B2]\], anesthetized, mechanically ventilated and instrumented pigs were randomly assigned to NA (increments of 0.06 μg/kg/min until maximal heart rate of 160/min; *n*= 8) or AVP (1--5 ng/kg/min, supplemented by NA if the maximum AVP dosage alone failed to maintain MAP; *n*= 9) to treat sepsis-associated hypotension. During continuous infusion of stable, nonradioactively labeled 1,2,3,4,5,6-^13^C~6~-glucose, blood isotope (gas chromatography--mass spectrometry) and expiratory gas ^13^CO~2~(nondispersive infrared spectrometry) enrichment was measured to derive gluconeogenesis and direct aerobic glucose oxidation \[[@B2]\] together with portal venous (Qpv) and hepatic arterial (Qha) blood flows (ultrasound flow probes). Data are the median (quartiles), and *P*\< 0.05 was regarded as significant for AVP versus NA.

Results
=======

At 24 hours of sepsis AVP resulted in significantly lower cardiac output and Qpv (20 (11--36) vs 26 (15--35) ml/kg/min), while Qha was comparable (3.0 (0.1--6.0) vs 2.1 (0.1--5.1) ml/kg/min). Despite significantly lower NA infusion rates (0.08 (0.0--0.64) vs 0.56 (0.05--4.36) μg/kg/min), AVP did not affect the parameters of energy expenditure (O~2~uptake (5.8 (3.9--8.1) vs 4.7 (4.2--6.6) ml/kg/min), CO~2~production (3.4 (2.3--4.9) vs 3.5 (2.9--4.7) ml/kg/min)), nor glucose metabolism (glucose oxidation 3.9 (0.6--4.6) vs 3.7 (0.6--4.6) mg/kg/min; gluconeogenesis 6.8 (4.6--8.5) vs 7.2 (4.9--11.0) mg/kg/min).

Conclusion
==========

Given the markedly lower NA infusion rates, the unchanged parameters of substrate utilization suggest improved cellular energy metabolism during AVP infusion.
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